International Journal of Clinical Research

Objective To explore the actual effectiveness of using ezetimibe combined with atorvastatin in the treatment of elderly patients with poor blood lipid control and coronary heart disease. Methods Elderly patients with coronary heart disease who received treatment in our hospital from December 2023 to December 2024 due to poor blood lipid control were selected as the study sample. They were randomly divided into a reference group (40 cases, treated with atorvastatin) and an experimental group (40 cases, treated with ezetimibe combined with atorvastatin) according to the envelope method. Compare the differences in blood lipid levels and incidence of adverse reactions between two groups. Results Compared with the reference group, the experimental group had significantly lower levels of TG, TC, and LDL-C, and significantly higher levels of HDL-C (P<0.05); The incidence of adverse reactions in the experimental group was significantly lower (P<0.05). Conclusion The combination of ezetimibe and atorvastatin is effective in treating elderly coronary heart disease with poor blood lipid control, effectively optimizing blood lipid indicators and reducing the incidence of adverse reactions.

Elderly coronary heart disease; Poor blood lipid control; Yizhe Maibu; Atorvastatin; Adverse reactions